Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
CUTE-IPS
Prévention du Cancer du Col de l'UTÉrus Par dépistage d'Une Infection Partageable Sexuellement
1 other identifier
interventional
400
1 country
1
Brief Summary
We propose a cross-sectional study to explore the acceptability and feasibility of HPV self-sampling among Quebec women. The study will invite eligible women to self-sample for HPV at home. The HPV risk factors of patients included in the study will be taken into consideration (vaccination, smoking, number of partners, date of last screening, etc.).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2022
CompletedStudy Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2022
CompletedFirst Posted
Study publicly available on registry
June 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedJune 10, 2022
June 1, 2022
1 month
March 10, 2022
June 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the acceptability of HPV self-sampling by patients
percentage of patients who prefer HPV testing to traditional cytology
2 months following recruitment
Secondary Outcomes (3)
Evaluate the percentage of samples collected correctly by patients
2 months following recruitment
Evaluate the return rate of mailed kits
2 months following recruitment
Calculate the HPV positivity rate in a population sample
2 months following recruitment
Study Arms (1)
HPV self-sampling group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Speak and understand French without help
- Have internet access (for completing forms)
- Have a mailing address
You may not qualify if:
- Known positive HPV status • Have already had a hysterectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, j1n4j6, Canada
Related Publications (1)
Ruel-Laliberte J, Jacob-Wagner M, Bestman-Smith J, Pare J. Acceptability and Preferences of Dry HR HPV Self-Sampling Mailed Kits Among Canadian Women: A Cross-Sectional Study. J Obstet Gynaecol Can. 2023 Apr;45(4):261-266. doi: 10.1016/j.jogc.2023.02.012. Epub 2023 Mar 3.
PMID: 36870436DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 10, 2022
First Posted
June 10, 2022
Study Start
April 4, 2022
Primary Completion
May 15, 2022
Study Completion
June 30, 2022
Last Updated
June 10, 2022
Record last verified: 2022-06